Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Sancken

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Fetal Diagnosis and Therapy|February 11, 2003
Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG)U Sancken, D Bahner
Lancet (London, England)|June 1, 1996
Computer software programs and Down's syndrome risk calculationsB Eiben, U Sancken
DTW. Deutsche Tierarztliche Wochenschrift|January 1, 1988
[Biotelemetrically established daily profile of the core body temperature of the female fallow deer (Dama dama L.) following immobilization with the Hellabrunner mixture in various environmental temperatures]U Sancken, K Fischer
Prenatal Diagnosis|March 22, 2001
Preliminary data on an association between blood groups and serum markers used for the so-called "triple screening": free oestriol MoM values are decreased in rhesus-negative (Rh-) womenU Sancken, I Bartels
Zeitschrift Fur Geburtshilfe Und Perinatologie|August 1, 1994
[Prenatal risk index for fetal Down's syndrome with serum markers. Comment on the contribution by R. Benz, U. Müller, M. Krahner-Pilat, S. Wagner-Geuder, R. Terinde: Serum screening for Down's syndrome in women less than 35 years of age with an age-independent index]I Bartels, U Sancken
Prenatal Diagnosis|August 1, 1995
The effect of thermal instability of intact human chorionic gonadotropin (ihCG) on the application of its free beta-subunit (free beta hCG) as a serum marker in Down syndrome screeningU Sancken, D Bahner
Prenatal Diagnosis|May 22, 2001
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?U Sancken, I Bartels
Prenatal Diagnosis|March 1, 1994
Prenatal detection of X-linked ichthyosis by maternal serum screening for Down syndromeI Bartels, J Caesar, U Sancken
Prenatal Diagnosis|October 16, 1999
A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratoriesU Sancken, I Bartels, F Louwen, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|March 1, 1992
[Martin-Bell syndrome. Improved possibilities for molecular genetic diagnosis]B Zoll, J Bal, J Pohnke, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Fetal Diagnosis and Therapy|February 11, 2003
Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG)U Sancken, D Bahner
Lancet (London, England)|June 1, 1996
Computer software programs and Down's syndrome risk calculationsB Eiben, U Sancken
DTW. Deutsche Tierarztliche Wochenschrift|January 1, 1988
[Biotelemetrically established daily profile of the core body temperature of the female fallow deer (Dama dama L.) following immobilization with the Hellabrunner mixture in various environmental temperatures]U Sancken, K Fischer
Prenatal Diagnosis|March 22, 2001
Preliminary data on an association between blood groups and serum markers used for the so-called "triple screening": free oestriol MoM values are decreased in rhesus-negative (Rh-) womenU Sancken, I Bartels
Zeitschrift Fur Geburtshilfe Und Perinatologie|August 1, 1994
[Prenatal risk index for fetal Down's syndrome with serum markers. Comment on the contribution by R. Benz, U. Müller, M. Krahner-Pilat, S. Wagner-Geuder, R. Terinde: Serum screening for Down's syndrome in women less than 35 years of age with an age-independent index]I Bartels, U Sancken
Prenatal Diagnosis|August 1, 1995
The effect of thermal instability of intact human chorionic gonadotropin (ihCG) on the application of its free beta-subunit (free beta hCG) as a serum marker in Down syndrome screeningU Sancken, D Bahner
Prenatal Diagnosis|May 22, 2001
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?U Sancken, I Bartels
Prenatal Diagnosis|March 1, 1994
Prenatal detection of X-linked ichthyosis by maternal serum screening for Down syndromeI Bartels, J Caesar, U Sancken
Prenatal Diagnosis|October 16, 1999
A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratoriesU Sancken, I Bartels, F Louwen, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|March 1, 1992
[Martin-Bell syndrome. Improved possibilities for molecular genetic diagnosis]B Zoll, J Bal, J Pohnke, et al.
Pageof 2